Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study

Autor: Chatziioannou, E., Higuita, L.M. Serna, Kreft, S., Kandolf, L., Dujovic, B., Reinhardt, L., Tamara, E., Marquez-Rodas, I., Fortuna, A.R.F.P., Nübling, A., Niessner, H., Forschner, A., Garbe, C., Popovic, A., Mirjana, B., Meier, F., Eigentler, T., Leiter, U., Flatz, L., Sinnberg, T., Amaral, T.
Zdroj: In ESMO Open August 2024 9(8)
Databáze: ScienceDirect